|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q61820611
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000330.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q61820611
|
|
024
|
|
|
‡a
0000-0002-7320-3832
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q61820611
|
|
100
|
0 |
|
‡a
Juan Angel Recio
‡c
researcher ORCID ID = 0000-0002-7320-3832
‡9
en
|
|
375
|
|
|
‡a
1
‡2
iso5218
|
|
400
|
0 |
|
‡a
Juan Angel Recio
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation
|
|
670
|
|
|
‡a
Author's ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment
|
|
670
|
|
|
‡a
Author's Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1
|
|
670
|
|
|
‡a
Author's cDNA isolation, expression, and chromosomal localization of the mouse pcph proto-oncogene
|
|
670
|
|
|
‡a
Author's Combination therapy with vemurafenib
|
|
670
|
|
|
‡a
Author's Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
|
|
670
|
|
|
‡a
Author's Early evolutionary divergence between papillary and anaplastic thyroid cancers.
|
|
670
|
|
|
‡a
Author's Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
|
|
670
|
|
|
‡a
Author's Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines.
|
|
670
|
|
|
‡a
Author's Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations.
|
|
670
|
|
|
‡a
Author's Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway.
|
|
670
|
|
|
‡a
Author's Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
|
|
670
|
|
|
‡a
Author's Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1
|
|
670
|
|
|
‡a
Author's Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction.
|
|
670
|
|
|
‡a
Author's Influence of Ras and retinoic acid on nerve growth factor induction of transin gene expression in PC12 cells.
|
|
670
|
|
|
‡a
Author's Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
|
|
670
|
|
|
‡a
Author's Lkb1 loss promotes tumor progression of BRAF
|
|
670
|
|
|
‡a
Author's Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas
|
|
670
|
|
|
‡a
Author's Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth
|
|
670
|
|
|
‡a
Author's Morphometric and immunocytochemical study of the fetal, infant, and adult human vas deferens.
|
|
670
|
|
|
‡a
Author's Neonatal sunburn and melanoma in mice
|
|
670
|
|
|
‡a
Author's New approach to cancer therapy based on a molecularly defined cancer classification.
|
|
670
|
|
|
‡a
Author's Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice
|
|
670
|
|
|
‡a
Author's Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein.
|
|
670
|
|
|
‡a
Author's Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF
|
|
670
|
|
|
‡a
Author's Retinoic acid stimulates HIV-1 transcription in human neuroblastoma SH-SY5Y cells
|
|
670
|
|
|
‡a
Author's STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation
|
|
670
|
|
|
‡a
Author's TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
|
|
670
|
|
|
‡a
Author's The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells.
|
|
670
|
|
|
‡a
Author's The human PCPH proto-oncogene: cDNA identification, primary structure, chromosomal mapping, and expression in normal and tumor cells
|
|
670
|
|
|
‡a
Author's Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF
|
|
909
|
|
|
‡a
(orcid) 0000000273203832
‡9
1
|
|
919
|
|
|
‡a
oralmethylthioadenosineadministrationattenuatesfibrosisandchronicliverdiseaseprogressioninmdr2mice
‡A
Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice
‡9
1
|
|
919
|
|
|
‡a
newapproachtocancertherapybasedonamolecularlydefinedcancerclassification
‡A
New approach to cancer therapy based on a molecularly defined cancer classification.
‡9
1
|
|
919
|
|
|
‡a
neonatalsunburnandmelanomainmice
‡A
Neonatal sunburn and melanoma in mice
‡9
1
|
|
919
|
|
|
‡a
morphometricandimmunocytochemicalstudyofthefetalinfantandadulthumanvasdeferens
‡A
Morphometric and immunocytochemical study of the fetal, infant, and adult human vas deferens.
‡9
1
|
|
919
|
|
|
‡a
methylthioadenosinemtainhibitsmelanomacellproliferationandinvivotumorgrowth
‡A
Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth
‡9
1
|
|
919
|
|
|
‡a
lkb1losspromotestumorprogressionofbrafv600einducedlungadenomas
‡A
Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas
‡9
1
|
|
919
|
|
|
‡a
lkb1losspromotestumorprogressionofbraf
‡A
Lkb1 loss promotes tumor progression of BRAF
‡9
1
|
|
919
|
|
|
‡a
ink4aarfdeficiencypromotesultravioletradiationinducedmelanomagenesis
‡A
Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis.
‡9
1
|
|
919
|
|
|
‡a
influenceofrasandretinoicacidonnervegrowthfactorinductionoftransingeneexpressioninpc12cells
‡A
Influence of Ras and retinoic acid on nerve growth factor induction of transin gene expression in PC12 cells.
‡9
1
|
|
919
|
|
|
‡a
humanumbilicalcordbloodcellsprotectoligodendrocytesfrombrainischemiathroughaktsignaltransduction
‡A
Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction.
‡9
1
|
|
919
|
|
|
‡a
hepatocytegrowthfactorscatterfactorinducesfeedbackupregulationofcd44v6inmelanomacellsthroughegr1
‡A
Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1
‡9
1
|
|
919
|
|
|
‡a
hepatocytegrowthfactorscatterfactoractivatesproliferationinmelanomacellsthroughp38mapkatf2andcyclind1
‡A
Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
‡9
1
|
|
919
|
|
|
‡a
geneticprofileofgnaqmutatedbluemelanocyticneoplasmsrevealsmutationsingeneslinkedtogenomicinstabilityandthepi3kpathway
‡A
Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway.
‡9
1
|
|
919
|
|
|
‡a
geneticevolutionofnevusofotarevealsclonalheterogeneityacquiringbap1andtp53mutations
‡A
Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations.
‡9
1
|
|
919
|
|
|
‡a
expressionoftheproteinproductofthepcphprotooncogeneinhumantumorcelllines
‡A
Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines.
‡9
1
|
|
919
|
|
|
‡a
epidermalgrowthfactorreceptorsignalinginhepatocellularcarcinomainflammatoryactivationandanewintracellularregulatorymechanism
‡A
Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
‡9
1
|
|
919
|
|
|
‡a
earlyevolutionarydivergencebetweenpapillaryandanaplasticthyroidcancers
‡A
Early evolutionary divergence between papillary and anaplastic thyroid cancers.
‡9
1
|
|
919
|
|
|
‡a
combinationtherapywithvemurafenibplx4032rg7204andmetformininmelanomacelllineswithdistinctdrivermutations
‡A
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
‡9
1
|
|
919
|
|
|
‡a
combinationtherapywithvemurafenib
‡A
Combination therapy with vemurafenib
‡9
1
|
|
919
|
|
|
‡a
cdnaisolationexpressionandchromosomallocalizationofthemousepcphprotooncogene
‡A
cDNA isolation, expression, and chromosomal localization of the mouse pcph proto-oncogene
‡9
1
|
|
919
|
|
|
‡a
bothnormalandtransformingpcphproteinshaveguanosinediphosphataseactivitybutonlytheoncoproteincooperateswithrasinactivatingextracellularsignalregulatedkinaseerk1
‡A
Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated kinase ERK1
‡9
1
|
|
919
|
|
|
‡a
aldh1a3isepigeneticallyregulatedduringmelanocytetransformationandisatargetformelanomatreatment
‡A
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment
‡9
1
|
|
919
|
|
|
‡a
mousemodeluncoverslkb1asanuvbinduceddnadamagesensormediatingcdkn1ap21waf1cip1degradation
‡A
A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation
‡9
1
|
|
919
|
|
|
‡a
uncouplingofthelkb1ampkalphaenergysensorpathwaybygrowthfactorsandoncogenicbraf
‡A
Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF
‡9
1
|
|
919
|
|
|
‡a
humanpcphprotooncogenecdnaidentificationprimarystructurechromosomalmappingandexpressioninnormalandtumorcells
‡A
The human PCPH proto-oncogene: cDNA identification, primary structure, chromosomal mapping, and expression in normal and tumor cells
‡9
1
|
|
919
|
|
|
‡a
dualpi3kmtorinhibitorpi103promotesimmunosuppressioninvivotumorgrowthandincreasessurvivalofsorafenibtreatedmelanomacells
‡A
The dual PI3K/mTOR inhibitor PI-103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib-treated melanoma cells.
‡9
1
|
|
919
|
|
|
‡a
tet2controlschemoresistantslowcyclingcancercellsurvivalandtumorrecurrence
‡A
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
‡9
1
|
|
919
|
|
|
‡a
stk11lkb1missensesomaticmutantisoformspromotetumorgrowthmotilityandinflammation
‡A
STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation
‡9
1
|
|
919
|
|
|
‡a
retinoicacidstimulateshiv1transcriptioninhumanneuroblastomashsy5ycells
‡A
Retinoic acid stimulates HIV-1 transcription in human neuroblastoma SH-SY5Y cells
‡9
1
|
|
919
|
|
|
‡a
proteinargininemethyltransferase5regulateserk12signaltransductionamplitudeandcellfatethroughcraf
‡A
Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF
‡9
1
|
|
919
|
|
|
‡a
partialdepletionofintracellularatpmediatesthestresssurvivalfunctionofthepcphoncoprotein
‡A
Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein.
‡9
1
|
|
946
|
|
|
‡a
b
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000059476995
|
|
996
|
|
|
‡2
LC|n 86000401
|
|
996
|
|
|
‡2
ISNI|0000000072117727
|
|
996
|
|
|
‡2
BNC|981058511095206706
|
|
996
|
|
|
‡2
ISNI|0000000059558392
|
|
996
|
|
|
‡2
BNE|XX1638710
|
|
996
|
|
|
‡2
LC|no2009171683
|
|
996
|
|
|
‡2
ISNI|0000000080784909
|
|
996
|
|
|
‡2
DNB|1049623002
|
|
996
|
|
|
‡2
NUKAT|n 2018049863
|
|
996
|
|
|
‡2
BNE|XX1760511
|
|
996
|
|
|
‡2
BNE|XX4792963
|
|
996
|
|
|
‡2
BNE|XX5468318
|
|
996
|
|
|
‡2
BNC|981061106266406706
|
|
996
|
|
|
‡2
SUDOC|252718852
|
|
996
|
|
|
‡2
ISNI|0000000093003470
|
|
996
|
|
|
‡2
LC|n 86041504
|
|
996
|
|
|
‡2
SUDOC|160476577
|
|
996
|
|
|
‡2
BNC|981058521814206706
|
|
996
|
|
|
‡2
BIBSYS|15038853
|
|
996
|
|
|
‡2
ISNI|0000000082478833
|
|
996
|
|
|
‡2
LC|no2020121270
|
|
996
|
|
|
‡2
LC|no2019137509
|
|
996
|
|
|
‡2
BNC|981058530155506706
|
|
996
|
|
|
‡2
BNE|XX1025977
|
|
996
|
|
|
‡2
ISNI|0000000392077330
|
|
996
|
|
|
‡2
J9U|987007433524105171
|
|
996
|
|
|
‡2
NTA|07261370X
|
|
996
|
|
|
‡2
BNE|XX1177413
|
|
996
|
|
|
‡2
SUDOC|080482376
|
|
996
|
|
|
‡2
NII|DA10306029
|
|
996
|
|
|
‡2
DNB|134065557
|
|
996
|
|
|
‡2
CAOONL|ncf11299861
|
|
996
|
|
|
‡2
BNF|16582352
|
|
996
|
|
|
‡2
BNC|981058526414006706
|
|
996
|
|
|
‡2
LC|no 92007124
|
|
996
|
|
|
‡2
ISNI|000000002260069X
|
|
996
|
|
|
‡2
NII|DA08976867
|
|
996
|
|
|
‡2
ISNI|0000000060486795
|
|
996
|
|
|
‡2
LC|n 79141662
|
|
996
|
|
|
‡2
LC|no2010164908
|
|
996
|
|
|
‡2
DNB|1281779334
|
|
996
|
|
|
‡2
BNCHL|10000000000000000089972
|
|
996
|
|
|
‡2
J9U|987007280699705171
|
|
996
|
|
|
‡2
BAV|495_37645
|
|
996
|
|
|
‡2
RERO|A000138106
|
|
996
|
|
|
‡2
LC|no2016087005
|
|
996
|
|
|
‡2
ISNI|0000000365966239
|
|
996
|
|
|
‡2
BNE|XX6057273
|
|
996
|
|
|
‡2
BNE|XX847012
|
|
996
|
|
|
‡2
BNC|981058521780906706
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
